LLY vs UHS
By Alex · Tickerpine
Eli Lilly and Company vs Universal Health Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | UHS |
|---|---|---|
| Price | $1,273.46 | $186.89 |
| Market cap | $1.14T | $11.01B |
| P/E ratio | 42.7 | 7.4 |
| ROE | 102.29% | 20.95% |
| Profit margin | 33.53% | 8.42% |
| Revenue growth | 47.70% | 8.30% |
| Dividend yield | 0.54% | 0.43% |
| Beta | 0.45 | 1.03 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs UHS in plain English
- LLY is the bigger company — about 103.1× the market cap of UHS.
- UHS is cheaper on earnings (P/E 7.4 vs 42.7).
- LLY earns a higher return on equity (102% vs 21%).
- LLY is growing revenue faster (48% vs 8%).
- LLY has the higher dividend yield (0.54% vs 0.43%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
UHS return calculator
See what $1,000 in Universal Health Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.